Literature DB >> 34272669

The contribution of bovines to human health against viral infections.

AbdulRahman A Saied1,2, Asmaa A Metwally3, Hams M A Mohamed4, Mohie A M Haridy5.   

Abstract

In the last 40 years, novel viruses have evolved at a much faster pace than other pathogens. Viral diseases pose a significant threat to public health around the world. Bovines have a longstanding history of significant contributions to human nutrition, agricultural, industrial purposes, medical research, drug and vaccine development, and livelihood. The life cycle, genomic structures, viral proteins, and pathophysiology of bovine viruses studied in vitro paved the way for understanding the human counterparts. Calf model has been used for testing vaccines against RSV, papillomavirus vaccines and anti-HCV agents were principally developed after using the BPV and BVDV model, respectively. Some bovine viruses-based vaccines (BPIV-3 and bovine rotaviruses) were successfully developed, clinically tried, and commercially produced. Cows, immunized with HIV envelope glycoprotein, produced effective broadly neutralizing antibodies in their serum and colostrum against HIV. Here, we have summarized a few examples of human viral infections for which the use of bovines has contributed to the acquisition of new knowledge to improve human health against viral infections covering the convergence between some human and bovine viruses and using bovines as disease models. Additionally, the production of vaccines and drugs, bovine-based products were covered, and the precautions in dealing with bovines and bovine-based materials.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bovine-based products; Bovines; COVID-19; Contribution; Human viruses; One medicine; Transchromosomic bovines

Year:  2021        PMID: 34272669     DOI: 10.1007/s11356-021-14941-z

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  5 in total

1.  Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction.

Authors:  Satoshi Oshiro; Naeko Mizutani; Tatsuya Tada; Jun-Ichiro Sekiguchi; Masao Takahashi; Teruo Kirikae
Journal:  Int Dairy J       Date:  2022-06-10       Impact factor: 3.572

2.  Besides human booster doses: Could vaccinating highly susceptible animals to SARS-CoV-2 be the needed urgent strategic step?

Authors:  AbdulRahman A Saied
Journal:  Int J Surg       Date:  2022-07-05       Impact factor: 13.400

Review 3.  Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.

Authors:  AbdulRahman A Saied; Manuela Sales Lima Nascimento; Adriano Henrique do Nascimento Rangel; Krzysztof Skowron; Katarzyna Grudlewska-Buda; Kuldeep Dhama; Jaffer Shah; Ahmed Abdeen; Fouad S El-Mayet; Hassan Ahmed; Asmaa A Metwally
Journal:  J Med Virol       Date:  2022-06-11       Impact factor: 20.693

4.  Spillover zoonotic 'Langya virus': is it a matter of concern?

Authors:  Om Prakash Choudhary; Mathumalar Loganathan Fahrni; Asmaa A Metwally; AbdulRahman A Saied
Journal:  Vet Q       Date:  2022-12       Impact factor: 8.071

Review 5.  Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article.

Authors:  AbdulRahman A Saied; Asmaa A Metwally; Moses Alobo; Jaffer Shah; Khan Sharun; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-01-19       Impact factor: 6.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.